Table 2 Biomarkers of liver lesions

Control

38.41±2.25^{a, c}

103.20 ± 2.03^a

119.08±0.60^a

0.566±0.01^a

28.02±0.54^a

CCl₄

224.56± 2.59^b

333.34 ± 2.11^b

201.83±2.08^b

4.350±0.40^b

59.33±0.94^b

GW

37.04±0.90^{a, c}

104.25 ± 0.44^a

117.39±0.70^{a, c}

0.582±0.02^a

22.66±0.28^{c, d}

GE

39.71 ±0.84^c

106.70 ± 2.37^a

117.48±1.11^{a, c}

0.661±0.04^a

21.48±0.33^d

MW

34.71 ± 0.36^a

105.83 ± 1.42^a

118.33±0.57^{a, c}

0.653±0.03^a

23.98±1.23^c

ME

35.59 ± 0.14^{a, c}

104.58 ± 1.40^a

115.20±1.66^c

0.650±0.01^a

22.40±0.93^{c, d}

CCl₄+GW

66.38 ± 1.64^d

128.75±2.13^d

139.01±0.46^d

1.75±0.06^c

37.01±0.60^e

CCl₄+GE

88.16±1.30^e

134.66±1.56^e

142.00±0.78^d

1.65±0.04^c

33.13±1.46^f

CCl₄+MW

89.02±2.10^e

134.98±1.81^e

138.78±0.25^d

1.95±0.05^d

37.04±0.57^e

CCl₄+ME

64.62±1.69^d

120.60±0.68^f

138.10±1.70^d

2.01±0.04^d

37.11±1.04^e